ReShape Lifesciences Inc (NASDAQ:RSLS) currently has a daily average trading volume of 9.18M but it saw 21862489 shares traded in last market. With a market cap of 3.86M USD, the company’s current market price of $0.34 came falling about -9.71 while comparing to the previous closing price of $0.38. In past 52 weeks, the stock remained buoying in the range of price level as high as $29.00 and as low as $0.34. In the recent trading on the day, stock has struck highest price mark of $0.3 while lowest mark touched by it was $0.3757.
Taking a look at 20-day trading activity of ReShape Lifesciences Inc (RSLS) gives us an average price of $0.5698, while its current price level is -98.82% below from 52-week high level whereas it is -0.66% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.3987 while that of 200 days or SMA-200 reads an average of $5.9675. A closer look into the stock’s movement over the week reveals that its volatility is standing at 43.62% during that period while stretching the period over a month that decreases to 36.99%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 39.68 which implies that the stock is in neutral territory.
Over the week, RSLS’s stock price is moving -23.96% down while it is -50.55% when we observe its performance for the past one month. Year-to-date it is -92.33% down and over the past year, the stock is showing a downside performance of -96.45%.
The company is expected to be releasing its next quarterly report on 2024-Nov-13, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, ReShape Lifesciences Inc’s total number of outstanding shares is 11.28M with 14.01% of that held by the insiders while 16.64% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -222.46%. Stock’s beta reads 1.21. Stock has a price to sale or P/S ratio amounts to 0.48. Its return on asset (ROA) is -91.67% on average.
